Bio-Techne (TECH) Receivables (2016 - 2025)
Historic Receivables for Bio-Techne (TECH) over the last 16 years, with Q4 2025 value amounting to $184.6 million.
- Bio-Techne's Receivables fell 1529.14% to $184.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $184.6 million, marking a year-over-year decrease of 1529.14%. This contributed to the annual value of $206.9 million for FY2025, which is 1429.94% down from last year.
- Per Bio-Techne's latest filing, its Receivables stood at $184.6 million for Q4 2025, which was down 1529.14% from $183.9 million recorded in Q3 2025.
- In the past 5 years, Bio-Techne's Receivables ranged from a high of $241.4 million in Q2 2024 and a low of $145.4 million during Q2 2021
- For the 5-year period, Bio-Techne's Receivables averaged around $196.5 million, with its median value being $203.3 million (2022).
- In the last 5 years, Bio-Techne's Receivables skyrocketed by 3434.42% in 2021 and then plummeted by 1778.86% in 2025.
- Quarter analysis of 5 years shows Bio-Techne's Receivables stood at $152.9 million in 2021, then rose by 20.84% to $184.8 million in 2022, then grew by 12.28% to $207.5 million in 2023, then increased by 5.06% to $217.9 million in 2024, then fell by 15.29% to $184.6 million in 2025.
- Its Receivables stands at $184.6 million for Q4 2025, versus $183.9 million for Q3 2025 and $206.9 million for Q2 2025.